Insiders who reported open-market trades in the last 12 months at the companies Mark W. Hahn files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Meredith Manning - $229K in SLNO purchases and sales in the last 12 months
Michael F. Huang - $200K in SLNO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Mark W. Hahn is a corporate insider of SOLENO THERAPEUTICS INC (SLNO). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Mark W. Hahn last file a Form 4?
The most recent primary Form 4 on record is dated 18 May 2026, one of 14 filings going back to 2024.
Has Mark W. Hahn been buying or selling stock?
Recorded transactions: 0 open-market purchases and 17 open-market sales ($11.26M) across all tracked filings.
Mark W. Hahn files SEC Form 4 reports at SOLENO THERAPEUTICS INC (SLNO). 14 SEC Form 4 filings on record going back to 2024, most recently on 18 May 2026. Most recent open-market trade: sold $2.75M of VRNA on 1 August 2025. Lifetime open-market sales: $11.26M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Mark W. Hahn.
InsiderAlpha's records for Mark W. Hahn go back to 2024: 14 primary Form 4 filings, an average of 4.7 per year. 16 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
